|
It was reported that a 43-year-old caucasian female patient underwent a primary breast augmentation with a 545cc mentor memorygel xtra breast implant and experienced early onset seroma on the left side post-operatively, which was confirmed with a ct scan.The patient had an incision and drainage procedure to treat the abscess.As a result, the patient underwent explantation on (b)(6) 2025.
|
|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: seroma.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.Manufacturer¿s reference number: (b)(4).
|
|
On august 05, 2025, mentor received additional information regarding the patient's experience.It was reported that the patient also experienced a breast abscess.Section h6-health effect - clinical code has been updated to reflect this additional information.Reason for device explant and/or reoperation: seroma and breast abscess.Manufacturer¿s reference number: (b)(4).
|